Advanced search
Publication Cover
Human Vaccines & Immunotherapeutics Volume 16, 2020 - Issue 11
Submit an article Journal homepage
1,002
Views
4
CrossRef citations to date
0
Altmetric
Review

Review of long term immunogenicity and tolerability of live hepatitis A vaccine

Nitin Shaha Pediatrics Department, PD Hinduja Hospital, Mumbai, India
,
MMA Faridib Pediatrics Department, ERA’s Lucknow Medical College & Hospital, Lucknow, India
,
Monjori Mitrac Pediatrics Department, Institute of Child Health, Kolkata, India
,
Ashish Bavdekard Pediatrics Department, KEM Hospital, Pune, India
,
Archana Karadkhelee Medical Affairs Department, Wockhardt Ltd., Mumbai, IndiaCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0003-4727-487X
ORCID Icon,
Gaurav Puppalware Medical Affairs Department, Wockhardt Ltd., Mumbai, India
&
Rishi Jaine Medical Affairs Department, Wockhardt Ltd., Mumbai, India
 show all
Pages 2816-2821 | Received 21 Nov 2019, Accepted 09 Mar 2020, Published online: 03 Apr 2020

References

  • Franco E, Meleleo C, Serino L, Sorbara D, Zaratti L. Hepatitis A: epidemiology and prevention in developing countries. World J Hepatol. 2012;4:68–73. doi:10.4254/wjh.v4.i3.68.
  • Hepatitis A questions and answers for the public CDC; [accessed 2019 Sep 20]. https://www.cdc.gov/hepatitis/hav/afaq.htm
  • Gossner CM, Severi E, Danielsson N, Hutin Y, Coulombier D. Changing hepatitis A epidemiology in the European Union: new challenges and opportunities. Euro Surveill. 2015;20(16):21101. http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=21101.
  • Arankalle V, Mitra M, Bhave S, Ghosh A, Balasubramanian S, Chatterjee S, Choudhury J, Chitkara A, Kadhe G, Mane A, et al. Changing epidemiology of hepatitis Avirus in Indian children. Vaccine. 2014;4:7–13.
  • Hepatitis A vaccines – july 2012 WHO position paper; [accessed 2019 Sep 20]. https://www.who.int/immunization/position_papers/PP_hep_A_july2012_summary.pdf.
  • Chen Y, Zhou C-L, Zhang X-J, Hao Z-Y, Zhang Y-H, Wang S-M, Ma JC, Zhao G, Qiu C, Zhao YL, et al. Immune memory at 17-years of follow-up of a single dose of live attenuated hepatitis A vaccine. Vaccine. 2018;36:114–21. doi:10.1016/j.vaccine.2017.11.036.
  • Beverley PCL. Immunology of vaccination. Br Med Bull. 2002;62:15–28. doi:10.1093/bmb/62.1.15.
  • Wang XY, Xu ZY, Ma JC, von Sejdlein L, Zhang Y, Hao ZY, Han OP, Zhang YL, Tian MY, Ouyang PY, et al. Long-term immunogenicity after single and booster dose of a live attenuated hepatitis A vaccine: results from 8-year follow-up. Vaccine. 2007;25:446–49. doi:10.1016/j.vaccine.2006.08.004.
  • Mao JS, Dong DX, Zhang HY, Chen NL, Zhang XY, Huang HY, Xie RY, Zhou TJ, Wan ZJ, Wang YZ, et al. Primary study of attenuated live hepatitis A vaccine (H2 strain) in humans. J Infect Dis. 1989;159:621–24. doi:10.1093/infdis/159.4.621.
  • Bhave S, Sapru A, Bavdekar A, Kapatkar V, Mane A. Long-term immunogenicity of single dose of live attenuated hepatitis A vaccine in Indian children. Indian Pediatr. 2015;52:687–90. doi:10.1007/s13312-015-0697-8.
  • Zhang QY, Chen H, Lin Z, Lin JM. Comparison of chemiluminescence enzyme immunoassay based on magnetic microparticles with traditional colorimetric ELISA for the detection of serum á-fetoprotein. J Pharm Analysis. 2012;2:130–35. doi:10.1016/j.jpha.2011.10.001.
  • Zhuang FC, Mao ZA, Jiang LM, Wu J, Chen YQ, Jiang Q, Chen NL, Chai SA, Mao JS. Long term immunogenicity and effectiveness of live attenuated hepatitis A vaccine (H2-strain)-a study on the result of 15 years’ follow up. Zhonghua Liu Xing Bing Xue Za Zhi. 2010 Dec;31:1332–35.
  • Zhuang F, Jiang Q, Gong Y. Epidemiological effects of live attenuated hepatitis A vaccine (H(2) strain): results of a 10-year observation. Zhonghua Liu Xing Bing Xue Za Zhi. 2001;22:188–90.
  • Zhuang FC, Qian W, Mao ZA, Gong YP, Jiang Q, Jiang LM, Chen NL, Chai SA, Mao JS. Persistent efficacy of live attenuated hepatitis A vaccine (H2-strain) after a mass vaccination program. Chin Med J (Engl). 2005;118:1851–56.
  • Faridi MMA, Shah N, Ghosh TK, Sankaranarayanan VS, Arankalle V, Aggarwal A, Sathiyasekaran M, Bhattacharya N, Vasanthi T, Chatterjee S, et al. Immunogenicity and safety of live attenuated hepatitis a vaccine: A multicentric study. Indian Pediatr. 2009;46:29–34.
  • Mitra M, Shah N, Faridi MMA, Ghosh A, Sankaranarayanan VS, Aggarwal A, Chatterjee S, Bhattacharya N, Kadhe G, Vishnoi G, et al. Long term follow-up study to evaluate immunogenicity and safety of a single dose of live attenuated hepatitis a vaccine in children. Hum Vaccin Immunother. 2015;11:1147–52. doi:10.4161/21645515.2014.979646.
  • Theeten H, Van Herck K, Van Der Meeren O, Crasta P, Van Damme P, Hens N. Long-term antibody persistence after vaccination with a 2-dose Havrix (inactivated hepatitis A vaccine): 20 years of observed data, and long-term model-based predictions. Vaccine. 2015;33:5723–27. doi:10.1016/j.vaccine.2015.07.008.
  • Fangcheng Z, Xuanvi W, Mingding C, Liming J, Jie W, Qi J, Yuanping G, Wen Q, Yajuan X, Jiangsen M. Era of vaccination heralds a decline in incidence of hepatitis A in high-risk groups in China. Hepat Mon. 2012;12:100–05. doi:10.5812/hepatmon.4907.
  • Rao S, Mao J, Motlekar S, Fangcheng Z, Kadhe G. A review of immunogenicity and tolerability of live attenuated Hepatitis A vaccine in children. Hum Vaccin Immunother. 2016 Dec; 12(12):3160–65. doi:10.1080/21645515.2016.1216286.
  • Chopra S Hepatitis A virus infection: treatment and prevention; [accessed 2019 Sep 20]. https://www.uptodate.com/contents/hepatitis-a-virus-infection-treatment-and-prevention/print
  • Vashishtha VM, Choudhury P, Kalra A, Bose A, Thacker N, Yewale VN, Bansal CP, Mehta PJ. Indian academy of pediatrics. Indian academy of pediatrics (IAP) Recommended immunization schedule for children aged 0 through 18 years – India, 2014 and updates on immunization. Indian Pediatr. 2014;51:785–803. doi:10.1007/s13312-014-0504-y.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.